Equities Research Analysts’ Ratings Reiterations for November 16th (ANIK, ANVS, APN, ASC, CDXS, COA, CPRT, CTL, CTRE, CVLT)

Equities Research Analysts’ ratings reiterations for Monday, November 16th:

Anika Therapeutics (NASDAQ:ANIK) had its buy rating reissued by analysts at B. Riley Financial. They currently have a $17.00 target price on the stock, down from their previous target price of $23.00.

Annovis Bio (NYSE:ANVS) had its buy rating reiterated by analysts at Roth Capital. Roth Capital currently has a $3.00 price target on the stock.

APN Resources (LON:APN) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 370 target price on the stock.

APN Resources (LON:APN) had its buy rating reiterated by analysts at Canaccord Genuity Group. Canaccord Genuity Group currently has a GBX 365 target price on the stock.

ASOS (LON:ASC) had its buy rating reissued by analysts at Shore Capital Group. They currently have a GBX 520 price target on the stock.

Codexis (NASDAQ:CDXS) had its overweight rating reiterated by analysts at Stephens. Stephens currently has a $5.00 target price on the stock.

Coats Group (LON:COA) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 135 target price on the stock.

Copart (NASDAQ:CPRT) had its equal weight rating reissued by analysts at Stephens. The firm currently has a $35.00 price target on the stock.

CleanTech Lithium (LON:CTL) had its speculative buy rating reissued by analysts at Canaccord Genuity Group. They currently have a GBX 15 price target on the stock.

CareTrust REIT (NYSE:CTRE) had its market outperform rating reaffirmed by analysts at Citizens Jmp. They currently have a $44.00 price target on the stock.

CommVault Systems (NASDAQ:CVLT) had its overweight rating reissued by analysts at Stephens. They currently have a $205.00 target price on the stock.

Ceres Power (LON:CWR) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 950 price target on the stock.

DeFi Technologies (NASDAQ:DEFT) had its buy rating reissued by analysts at B. Riley Financial. B. Riley Financial currently has a $0.64 target price on the stock, up from their previous target price of $0.62.

Adherex Technologies (NASDAQ:FENC) had its buy rating reissued by analysts at B. Riley Financial. B. Riley Financial currently has a $19.00 target price on the stock, up from their previous target price of $18.00.

Sensei Biotherapeutics (NASDAQ:FTH) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $60.00 price target on the stock.

Sensei Biotherapeutics (NASDAQ:FTH) had its buy rating reissued by analysts at Needham & Company LLC. Needham & Company LLC currently has a $56.00 price target on the stock.

Hasbro (NASDAQ:HAS) had its buy rating reissued by analysts at Roth Capital. The firm currently has a $136.00 target price on the stock, up from their previous target price of $125.00.

Intermediate Capital Group (LON:ICG) had its buy rating reissued by analysts at Berenberg Bank. They currently have a GBX 2,640 price target on the stock.

Land Securities Group (LON:LAND) had its buy rating reaffirmed by analysts at Deutsche Bank. The firm currently has a GBX 750 price target on the stock.

Maestrano Group (LON:MNO) had its buy rating reiterated by analysts at Berenberg Bank. They currently have a GBX 183 price target on the stock.

NIKE (NYSE:NKE) had its neutral rating reaffirmed by analysts at Cantor Fitzgerald. They currently have a $38.00 price target on the stock.

Oxford Nanopore Technologies (LON:ONT) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a GBX 300 target price on the stock.

Palo Alto Networks (NASDAQ:PANW) had its overweight rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $425.00 target price on the stock.

Palo Alto Networks (NASDAQ:PANW) had its buy rating reaffirmed by analysts at TD Cowen. They currently have a $440.00 target price on the stock.

Premier Foods (LON:PFD) had its buy rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 290 price target on the stock.

Precigen (NASDAQ:PGEN) had its buy rating reiterated by analysts at B. Riley Financial. The firm currently has a $11.00 target price on the stock, down from their previous target price of $12.00.

Prime Medicine (NASDAQ:PRME) had its buy rating reissued by analysts at HC Wainwright. They currently have a $8.00 price target on the stock.

SpaceX (NASDAQ:SPCX) had its outperform rating reaffirmed by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $225.00 target price on the stock.

Sirius Real Estate (LON:SRE) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 134 price target on the stock.

VersaBank (NASDAQ:VBNK) had its buy rating reaffirmed by analysts at Roth Capital. Roth Capital currently has a $32.00 price target on the stock, up from their previous price target of $28.00.

Wise (LON:WISE) had its buy rating reissued by analysts at Canaccord Genuity Group. They currently have a GBX 1,171 price target on the stock.

Receive News & Ratings for Anika Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anika Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.